Across all industries, the total number of companies on track to go public could make this week the most active for IPOs since 2021.

A major biotech company has announced plans to lay off more than 100 positions from its Franklin, Massachusetts, facility.

The latest firm to top up its venture capital coffers is Austin, Texas-based Santé Ventures, which on Monday announced its ...

A large biotech fund that's an insider at Cogent Biosciences recently sold millions of shares amid the company's best annual ...

WENZHOU, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- As the global pharmaceutical and healthcare ...

The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.

Explore how leadership in biotech drives success through a milestone approach, aligning teams and culture from science to ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

Pfizer has spent billions of dollars on acquisitions in the past few decades. Its biggest deals include Warner-Lambert, ...

Cantai launched in 2023 with a $3 million seed round. The company has raised $6.55 million to date at an undisclosed valuation, according to PitchBook. It develops drug candidates with special ...

For biotech companies the past two years have been challenging. Biotech investments have not reached the record levels of ...

As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's ...